glp-1 weight loss drug news today 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Serena Williams Is the Surprising

Reddy's Laboratories has launched Obeda, the countrys first DCGI-approved generic semaglutide inj

Yeo, Yee Hui, et al

1,2 As scientists continue to investigate established and new therapeutic applications, GLP-1 receptor (GLP-1R) agonists such as semaglutide, dulaglutide, and tirzepatide have become increasingly relevant tools in preclinical research

GLP-1 Receptor Agonists and the Eye: Evidence, Mechanisms, and Clinical Guidance A new multidisciplinary expert consensus published in Diabetes, Obesity & Metabolism (2025) brings clarity to a question often raised in clinical practice: Do GLP-1 receptor agonists increase the risk of ocular complications such as diabetic retinopathy or optic neuropathy

Awarded the Nobel Prize for Chemistry in 1958, Sangers method opened up a new pathway to the structural identification of gut hormones